Rare deleterious variants in GDF2 contribute to approximately 0.9%–6.8% childhood-onset PAH (Levy et al., 2016; Graf et al., 2018; Wang et al., 2019a; Zhu et al., 2019; Abman et al., 2022). The gene discussed is GDF2; the disease is pulmonary arterial hypertension.